Description
Christopher C. Cheung, MD, MPH, of Sunnybrook Health Sciences Centre, University of Toronto, is joined by guests Edward P. Gerstenfeld, MD, FHRS, of University of California, San Francisco, and Paul C. Zei, MD, PhD, FHRS, of Brigham and Women's Hospital to discuss the benefits and risks associated with pulsed field ablation and conventional thermal ablation in the content of paroxysmal atrial fibrillation.
Learning Objectives
- Evaluate the risks and mitigations of purlsed field ablation for paroxysmal atrial fibrillation.
- Evaluate the risks and mitigations of conventional thermal ablation for paroxysmal atrial fibrillation.
- Compare the effectiveness of purlsed field ablation to conventional thermal ablation for paroxysmal atrial fibrillation.
Article Authors and Podcast Contributors
Article Authors
Vivek Y. Reddy, M.D., Edward P. Gerstenfeld, M.D., Andrea Natale, M.D., William Whang, M.D., Frank A. Cuoco, M.D., Chinmay Patel, M.D., Stavros E. Mountantonakis, M.D., Douglas N. Gibson, M.D., John D. Harding, M.D., Christopher R. Ellis, M.D., Kenneth A. Ellenbogen, M.D., David B. DeLurgio, M.D., Jose Osorio, M.D., Anitha B. Achyutha, M.Tech., M.S.E., Christopher W. Schneider, M.Eng., Andrew S. Mugglin, Ph.D., Elizabeth M. Albrecht, Ph.D., Kenneth M. Stein, M.D., John W. Lehmann, M.D., M.P.H., and Moussa Mansour, M.D., for the ADVENT Investigators*
Podcast Contributors
Christopher C. Cheung, MD, MPH, of Sunnybrook Health Sciences Centre, University of Toronto
Edward P. Gerstenfeld, MD, FHRS, of University of California, San Francisco
Paul C. Zei, MD, PhD, FHRS, of Brigham and Women's Hospital
Disclosure Policy
ACE Disclosure Policy
The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.
Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.
ACCME Definition:
*An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Examples of such organizations include:
- Advertising, marketing, or communication firms whose clients are ineligible companies
- Bio-medical startups that have begun a governmental regulatory approval process
- Compounding pharmacies that manufacture proprietary compounds
- Device manufacturers or distributors
- Diagnostic labs that sell proprietary products
- Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
- Manufacturers of health-related wearable products
- Pharmaceutical companies or distributors
- Pharmacy benefit managers
- Reagent manufacturers or sellers
All relevant financial relationships have been mitigated.Host Disclosure(s):
C. Cheung: No relevant financial relationships with ineligible companies to disclose.
Contributor Disclosure(s):
E. Gerstenfeld: Honoraria/Speaking/Consulting Fee: Medtronic, Boston Scientific, Biosense Webster, Abbott, Thermedica; Other Non-Financial Relationships: Farapulse, Abbott Medical, Adaigo Medical, Boston Scientific
P. Zei: Honoraria/Speaking/Consulting Fee: Abbott, Biosense Webster Inc., Varian Medical Systems; Research (Contracted Grants for PIs Named Investigators Only): Daiichi, Biosense Webster Inc.; Stock Options (Publicly Traded): Affera, Inc.
Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
J. Glenn: No relevant financial relationships with ineligible companies to disclose.
S. Sailor: No relevant financial relationships with ineligible companies to disclose.